Jian‐She Wang

2.3k total citations
104 papers, 1.3k citations indexed

About

Jian‐She Wang is a scholar working on Surgery, Oncology and Epidemiology. According to data from OpenAlex, Jian‐She Wang has authored 104 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Surgery, 28 papers in Oncology and 24 papers in Epidemiology. Recurrent topics in Jian‐She Wang's work include Pediatric Hepatobiliary Diseases and Treatments (46 papers), Drug Transport and Resistance Mechanisms (27 papers) and Metabolism and Genetic Disorders (23 papers). Jian‐She Wang is often cited by papers focused on Pediatric Hepatobiliary Diseases and Treatments (46 papers), Drug Transport and Resistance Mechanisms (27 papers) and Metabolism and Genetic Disorders (23 papers). Jian‐She Wang collaborates with scholars based in China, United States and Austria. Jian‐She Wang's co-authors include Yi Lu, Jing‐Yu Gong, Meihong Zhang, Yi‐Ling Qiu, Xiuzhen Zhang, Kuerbanjiang Abuduxikuer, A. S. Knisely, Liting Li, Xin‐Bao Xie and Jiaqi Li and has published in prestigious journals such as PLoS ONE, Hepatology and Scientific Reports.

In The Last Decade

Jian‐She Wang

98 papers receiving 1.3k citations

Peers

Jian‐She Wang

SURGE

EPIDE

HEPAT

ONCOL

Martin Leníček Czechia

K Tanikawa Japan

André Geubel Belgium

Anders Nyberg Sweden

Francesco Azzaroli Italy

James L. Wisecarver United States

M Köllinger Germany

Hiroo Ohnishi Japan

Evangelos Triantafyllou United Kingdom

Abdurrahman Kadayıfçı Türkiye

Martin Leníček Czechia

Jian‐She Wang

334 ×0.7

SURGE

366 ×0.8

EPIDE

153 ×0.4

HEPAT

265 ×0.8

ONCOL

490 ×2.1

Citations per year, relative to Jian‐She Wang Jian‐She Wang (= 1×) peers Martin Leníček

Countries citing papers authored by Jian‐She Wang

Since Specialization

Citations

This map shows the geographic impact of Jian‐She Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jian‐She Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jian‐She Wang more than expected).

Fields of papers citing papers by Jian‐She Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jian‐She Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jian‐She Wang. The network helps show where Jian‐She Wang may publish in the future.

Co-authorship network of co-authors of Jian‐She Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Jian‐She Wang. A scholar is included among the top collaborators of Jian‐She Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jian‐She Wang. Jian‐She Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

She, Haicheng, Yi‐Ling Qiu, Ye Cheng, et al.. (2025). A liver-specific mouse model for MYO5B-associated cholestasis reveals a toxic gain-of-function as underlying disease mechanism. Biochemical and Biophysical Research Communications. 758. 151669–151669. 1 indexed citations

Li, Jiaqi, Yueyong Zhu, Mei Xue, et al.. (2025). Clinical features and long-term outcomes of patients with ZFYVE19 variants. Digestive and Liver Disease. 57(5). 1021–1027.

Wang, Renxue, Chenzhi Hao, Yi‐Ling Qiu, et al.. (2024). ZFYVE19 deficiency: a ciliopathy involving failure of cell division, with cell death. Journal of Medical Genetics. 61(8). 750–758. 2 indexed citations

Ding, Jian, Yi‐Ling Qiu, Renxue Wang, et al.. (2024). Loss of hepatocyte Usp53 protects mice from a form of xenobiotic-induced liver injury. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(3). 167624–167624. 2 indexed citations

Xing, Qinghe, et al.. (2023). Transcript selection for the genetic diagnosis of KIF12-associated progressive familial intrahepatic cholestasis. Gastroenterology report. 12. goad073–goad073. 2 indexed citations

Yang, H. J., et al.. (2023). Balanced Translocation Disrupting JAG1 Identified by Optical Genomic Mapping in Suspected Alagille Syndrome. Human Mutation. 2023. 1–7. 1 indexed citations

Wang, Jian‐She, et al.. (2023). Ursodeoxycholic acid administration did not reduce susceptibility to SARS‐CoV‐2 infection in children. Liver International. 43(9). 1950–1954. 9 indexed citations

Wang, Renxue, Jun Han, Jonathan A. Sheps, et al.. (2023). Comprehensive Bile Acid Profiling of ABCB4-mutated Patients and the Prognostic Role of Taurine-conjugated 3α,6α,7α,12α-Tetrahydroxylated Bile Acid in Cholestasis. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 1 indexed citations

Zhao, Jing, Yi Lu, Jonathan A. Sheps, et al.. (2022). Neonatal Dubin-Johnson Syndrome and its Differentiation from Biliary Atresia. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 2 indexed citations

10.

Abuduxikuer, Kuerbanjiang, Chenzhi Hao, Jing Zhang, et al.. (2022). Defining pathogenicity of NOTCH2 variants for diagnosis of Alagille syndrome type 2 using a large cohort of patients. Liver International. 42(8). 1836–1848. 4 indexed citations

11.

Zhao, Jing, Kenneth D.R. Setchell, Ying Gong, et al.. (2021). Genetic spectrum and clinical characteristics of 3β-hydroxy-Δ5-C27-steroid oxidoreductase (HSD3B7) deficiency in China. Orphanet Journal of Rare Diseases. 16(1). 417–417. 9 indexed citations

12.

Qiu, Yi‐Ling, Hongmei Xu, Jing Zhu, et al.. (2021). MYO5B‐associated diseases: Novel liver‐related variants and genotype‐phenotype correlation. Liver International. 42(2). 402–411. 11 indexed citations

13.

Yang, Ye, Jing Zhang, Liting Li, et al.. (2021). Whole-Genome Sequencing Reveals Large ATP8B1 Deletion/Duplications as Second Mutations Missed by Exome-Based Sequencing. Journal of Molecular Diagnostics. 23(11). 1491–1499. 2 indexed citations

14.

IJzendoorn, Sven C.D. van, et al.. (2020). Unequal Effects of Myosin 5B Mutations in Liver and Intestine Determine the Clinical Presentation of Low‐Gamma‐Glutamyltransferase Cholestasis. Hepatology. 72(4). 1461–1468. 19 indexed citations

15.

Abuduxikuer, Kuerbanjiang, Jing Zhang, Yi‐Ling Qiu, et al.. (2020). NBAS disease: 14 new patients, a recurrent mutation, and genotype–phenotype correlation among 24 Chinese patients. Hepatology Research. 50(11). 1306–1315. 9 indexed citations

16.

Liu, Bo, Bingbing Wu, Yi Lu, et al.. (2020). A Novel, Recurrent, 3.6-kb Deletion in the PYGL Gene Contributes to Glycogen Storage Disease Type VI. Journal of Molecular Diagnostics. 22(12). 1373–1382. 4 indexed citations

17.

Zhang, Jing, Jing‐Yu Gong, Liting Li, et al.. (2020). Low‐GGT intrahepatic cholestasis associated with biallelic USP53 variants: Clinical, histological and ultrastructural characterization. Liver International. 40(5). 1142–1150. 37 indexed citations

18.

Zhang, Jing, Jing‐Yu Gong, Chenzhi Hao, et al.. (2019). TJP2 hepatobiliary disorders: Novel variants and clinical diversity. Human Mutation. 41(2). 502–511. 24 indexed citations

19.

Wang, Jin, et al.. (2011). A new frame-shifting mutation of UGT1A1 gene causes type I Crigler-Najjar syndrome.. PubMed. 124(23). 4109–11. 4 indexed citations

20.

Wang, Jian‐She, et al.. (2003). BREASTFEEDING DOES NOT POSE ANY ADDITIONAL RISK OF IMMUNOPROPHYLAXIS FAILURE ON INFANTS OF HBV CARRIER MOTHERS. International Journal of Clinical Practice. 57(2). 100–102. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact